Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-01-31 08:57 am Unchanged | 13G | SURFACE ONCOLOGY INC SURF | Atlas Venture Fund IX L.P. | 2,945,453 4.87% | 0 (Unchanged) | View |
| 2022-01-25 11:32 am Unchanged | 13G | COGENT BIOSCIENCES INC COGT | Atlas Venture Fund IX L.P. | 916,196 2.3% | 0 (Unchanged) | View |
| 2022-01-25 11:30 am Unchanged | 13G | SURFACE ONCOLOGY INC SURF | Atlas Venture Fund IX L.P. | 2,945,453 6.38% | 0 (Unchanged) | View |
| 2022-01-25 11:28 am Unchanged | 13G | SPERO THERAPEUTICS INC SPRO | Atlas Venture Fund IX L.P. | 1,376,968 4.26% | 0 (Unchanged) | View |
| 2021-02-02 1:03 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | Atlas Venture Fund IX L.P. | 2,945,453 7.24% | -1,709,000 (-36.72%) | View |
| 2021-02-02 1:02 pm Unchanged | 13G | SPERO THERAPEUTICS INC SPRO | Atlas Venture Fund IX L.P. | 1,376,968 5.06% | 0 (Unchanged) | View |
| 2021-02-02 1:02 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Atlas Venture Fund IX L.P. | 916,196 8.08% | 916,196 (New Position) | View |
| 2020-12-28 07:39 am Purchase | 13D | SKILLZ INC SKLZ | Atlas Venture Fund IX L.P. | 23,284,403 8% | 23,284,403 (New Position) | View |
| 2020-02-04 3:00 pm Unchanged | 13G | UNUM THERAPEUTICS INC UMRX | Atlas Venture Fund IX L.P. | 3,361,535 10.96% | 0 (Unchanged) | View |
| 2020-02-04 2:58 pm Unchanged | 13G | SURFACE ONCOLOGY INC SURF | Atlas Venture Fund IX L.P. | 4,654,453 16.69% | 0 (Unchanged) | View |
| 2020-02-04 2:56 pm Unchanged | 13G | SPERO THERAPEUTICS INC SPRO | Atlas Venture Fund IX L.P. | 1,376,968 7.2% | 0 (Unchanged) | View |